The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ALECTOR INC COM 014442107 13,978 980,894 SH   SOLE   980,894 0 0
COINBASE GLOBAL INC COM CL A 19260Q107 8,909 46,922 SH   SOLE   46,922 0 0
FIRST FINL BANCORP OH COM 320209109 4,001 173,576 SH   SOLE   173,576 0 0
FOGHORN THERAPEUTICS INC COM 344174107 19,209 1,261,261 SH   SOLE   1,261,261 0 0
23ANDME HOLDING CO CLASS A COM 90138Q108 39,231 10,243,122 SH   SOLE   10,243,122 0 0
NGM BIOPHARMACEUTICALS INC COM 62921N105 11,387 746,674 SH   SOLE   746,674 0 0
ORIC PHARMACEUTICALS INC COM 68622P109 3,992 747,550 SH   SOLE   747,550 0 0
PMV PHARMACEUTICALS INC COM 69353Y103 48,654 2,336,909 SH   SOLE   2,336,909 0 0
RAPT THERAPEUTICS INC COM 75382E109 9,519 432,900 SH   SOLE   432,900 0 0
SURROZEN INC COM 86889P109 2,417 802,963 SH   SOLE   802,963 0 0
TENAYA THERAPEUTICS INC COM 87990A106 10,787 915,705 SH   SOLE   915,705 0 0